Published in Pharma Law Weekly, September 6th, 2005
U.S. BioDefense disputes the allegation claiming any partial payment schedules had been agreed to by UCL since negotiations have been ongoing for a full license agreement for the past few months.
U.S. BioDefense filed a Notice of Exercise prior to expiration and received a full term sheet for the license from UCL prior...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.